Dr Reddys Laboratories (RDY) Revenue (2020 - 2023)
Historic Revenue for Dr Reddys Laboratories (RDY) over the last 17 years, with Q4 2025 value amounting to $979.9 million.
- Dr Reddys Laboratories' Revenue fell 101.31% to $979.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $3.0 billion, marking a year-over-year increase of 543.66%. This contributed to the annual value of $3.8 billion for FY2025, which is 1376.12% up from last year.
- Per Dr Reddys Laboratories' latest filing, its Revenue stood at $979.9 million for Q4 2025, which was down 101.31% from -$75.1 million recorded in Q3 2025.
- Dr Reddys Laboratories' 5-year Revenue high stood at $990.0 million for Q4 2024, and its period low was -$75.1 million during Q3 2025.
- In the last 5 years, Dr Reddys Laboratories' Revenue had a median value of $801.0 million in 2022 and averaged $767.4 million.
- Its Revenue has fluctuated over the past 5 years, first surged by 2652.11% in 2023, then plummeted by 10784.18% in 2025.
- Over the past 5 years, Dr Reddys Laboratories' Revenue (Quarter) stood at $688.0 million in 2021, then rose by 11.48% to $767.0 million in 2022, then increased by 12.97% to $866.5 million in 2023, then grew by 14.25% to $990.0 million in 2024, then fell by 1.01% to $979.9 million in 2025.
- Its Revenue stands at $979.9 million for Q4 2025, versus -$75.1 million for Q3 2025 and $982.3 million for Q1 2025.